An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a public forum wrote that they’ve been taking Wegovy since January 2025 and lost almost 40 kg (about 88 pounds). They’re now 103 kg but were aiming for roughly 75 kg. Despite increasing their dose to 1.7 mg and doing a lot of strength training, their weight has stalled and they still have a high body-fat percentage. They’re asking why they’ve hit a plateau. Wegovy is the brand name for a drug whose active ingredient is semaglutide. Semaglutide is a lab-made version of a hormone your gut naturally makes after you eat. That hormone sends signals to your brain that lower appetite and slow how fast food leaves your stomach, so you feel full longer. Doctors prescribe Wegovy for weight loss at specific doses and it’s used together with diet and exercise. The information in the post is a single-person report — basically an anecdote, not a controlled study. What it shows is that this person had big initial weight loss, then reached a plateau even after raising the dose and doing strength workouts. Plateaus are common with weight-loss drugs: early weight loss tends to be faster, then slows as your body adjusts. The post doesn’t provide medical tests, body composition details, or verified timelines beyond the start date, so we can’t quantify exactly why their weight stopped dropping or how their muscle vs. fat changed. Why this matters is practical: many people take drugs like Wegovy hoping continuous weight loss. Hearing real users say they hit a long plateau is a reminder that these drugs aren’t magic permanent fixes. For someone trying to lose weight, it could mean re-evaluating calories, protein intake, strength training program, sleep, stress, or underlying medical issues (like thyroid problems). It also matters to people deciding whether to start the drug — expectations should include possible plateaus and the need for lifestyle changes and medical follow-up. There are important caveats. This is one person’s story, not proof of how Wegovy works for everyone. Semaglutide can have side effects like nausea, constipation, or gallbladder problems; stopping it can cause weight regain. Dose changes should only be done under a doctor’s guidance. Also, body composition can hide progress: gaining muscle while losing fat might keep the scale steady but improve health. Finally, if weight loss stalls despite reasonable efforts, a clinician can check for other causes and consider adjustments. Bottom line: Wegovy can produce big early losses, but plateaus are common; a medical review and a careful look at diet, training, and other health factors are the next sensible steps.
Source: r/Semaglutide